Stock’s Earning Overview BHP Billiton plc(NYSE:BBL): Abbott Laboratories(NYSE:ABT)

0
3

Many analysts are providing their Estimated Earnings analysis for BHP Billiton plc and for the current quarter 0 analysts have projected that the stock could give an Average Earnings estimate of $0/share. These analysts have also projected a Low Estimate of $0/share and a High Estimate of $0/share.

Some buy side analysts are also providing their Analysis on BHP Billiton plc, where 0 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 5 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for BHP Billiton plc might touch $52.09 high while the Average Price Target and Low price Target is $49.3 and $46.5 respectively.

BHP Billiton plc closed its last trading session at $41.28 with the loss of -0.73%. The Market Capitalization of the company stands at 110.29 Billion. The Company has 52-week high of $51.87 and 52-week low of $36.25. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -5.72% where SMA50 and SMA200 are -5.74% and -10.27% respectively. The Company Touched its 52-Week High on 07/02/19 and 52-Week Low on 11/27/18.

The Relative Volume of the company is 1.14 and Average Volume (3 months) is 1.22 million. The company’s P/E (price to earnings) ratio is 12.29 and Forward P/E ratio of 14.77.

The company shows its Return on Assets (ROA) value of 7.8%. The Return on Equity (ROE) value stands at 15.8%. While it’s Return on Investment (ROI) value is 14.7%.

While looking at the Stock’s Performance, BHP Billiton plc currently shows a Weekly Performance of -3.55%, where Monthly Performance is -6.07%, Quarterly performance is -18.3%, 6 Months performance is -18.67% and yearly performance percentage is -0.25%. Year to Date performance value (YTD perf) value is 2.65%. The Stock currently has a Weekly Volatility of 1.51% and Monthly Volatility of 1.26%.

Abbott Laboratories (ABT) will report its next earnings on Oct 16 BMO. The company reported the earnings of $0.82/Share in the last quarter where the estimated EPS by analysts was $0.8/share. The difference between the expected and actual EPS was $0.02/share, which represents an Earnings surprise of 2.5%.

Many analysts are providing their Estimated Earnings analysis for Abbott Laboratories and for the current quarter 19 analysts have projected that the stock could give an Average Earnings estimate of $0.84/share. These analysts have also projected a Low Estimate of $0.83/share and a High Estimate of $0.85/share.

In case of Revenue Estimates, 18 analysts have provided their consensus Average Revenue Estimates for Abbott Laboratories as 8.11 Billion. According to these analysts, the Low Revenue Estimate for Abbott Laboratories is 8.06 Billion and the High Revenue Estimate is 8.16 Billion. The company had Year Ago Sales of 7.66 Billion.

These analysts also forecasted Growth Estimates for the Current Quarter for ABT to be 12%. They are projecting Next Quarter growth of 16.05%. For the next 5 years, Abbott Laboratories is expecting Growth of 12.04% per annum, whereas in the past 5 years the growth was 12.5% per annum.

Some buy side analysts are also providing their Analysis on Abbott Laboratories, where 5 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 1 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Abbott Laboratories might touch $99 high while the Average Price Target and Low price Target is $94.32 and $90 respectively.

Abbott Laboratories closed its last trading session at $81.04 with the loss of -3.12%. The Market Capitalization of the company stands at 138.88 Billion. The Company has 52-week high of $88.76 and 52-week low of $65.44. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -5.22% where SMA50 and SMA200 are -6.72% and -0.78% respectively. The Company Touched its 52-Week High on 07/23/19 and 52-Week Low on 12/24/18.

The Relative Volume of the company is 1.3 and Average Volume (3 months) is 4.52 million. The company’s P/E (price to earnings) ratio is 47.76 and Forward P/E ratio of 21.68.

The company shows its Return on Assets (ROA) value of 4.2%. The Return on Equity (ROE) value stands at 9.4%. While it’s Return on Investment (ROI) value is 6.1%.

While looking at the Stock’s Performance, Abbott Laboratories currently shows a Weekly Performance of -4.07%, where Monthly Performance is -6.78%, Quarterly performance is -8.05%, 6 Months performance is -0.2% and yearly performance percentage is 9.68%. Year to Date performance value (YTD perf) value is 8.54%. The Stock currently has a Weekly Volatility of 2.33% and Monthly Volatility of 1.98%.

SHARE